BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10097830)

  • 1. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment.
    Choudhury L; Elliott P; Rimoldi O; Ryan M; Lammertsma AA; Boyd H; McKenna WJ; Camici PG
    Basic Res Cardiol; 1999 Feb; 94(1):49-59. PubMed ID: 10097830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.
    Sciagrà R; Passeri A; Cipollini F; Castagnoli H; Olivotto I; Burger C; Cecchi F; Pupi A
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1581-8. PubMed ID: 26121929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
    Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
    Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy.
    Gistri R; Cecchi F; Choudhury L; Montereggi A; Sorace O; Salvadori PA; Camici PG
    Am J Cardiol; 1994 Aug; 74(4):363-8. PubMed ID: 8059699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension.
    Parodi O; Neglia D; Palombo C; Sambuceti G; Giorgetti A; Marabotti C; Gallopin M; Simonetti I; L'Abbate A
    Circulation; 1997 Aug; 96(3):864-73. PubMed ID: 9264494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Eur Heart J; 1997 Dec; 18(12):1946-50. PubMed ID: 9447323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Am Heart J; 1998 Dec; 136(6):972-81. PubMed ID: 9842009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
    Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
    J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.
    Castagnoli H; Ferrantini C; Coppini R; Passeri A; Baldini K; Berti V; Cecchi F; Olivotto I; Sciagrà R
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2413-2422. PubMed ID: 27527796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
    Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
    Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET.
    Araujo LI; McFalls EO; Lammertsma AA; Jones T; Maseri A
    J Nucl Cardiol; 2001; 8(3):339-46. PubMed ID: 11391304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan.
    Iida H; Yokoyama I; Agostini D; Banno T; Kato T; Ito K; Kuwabara Y; Oda Y; Otake T; Tamura Y; Tadamura E; Yoshida T; Tamaki N
    Eur J Nucl Med; 2000 Feb; 27(2):192-201. PubMed ID: 10755725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.
    Parodi O; Neglia D; Sambuceti G; Marabotti C; Palombo C; Donato L
    Drugs; 1992; 44 Suppl 1():48-55. PubMed ID: 1283584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of transmural gradient of blood flow in myocardial ischemia with real-time myocardial contrast echocardiography and dipyridamole stress test.
    Yao GH; Zhang C; Sun FR; Zhang M; Zhao YX; Zhang PF; Zhong L; Ding SF; Chen WQ; Li XN; Zhang Y
    Ultrasound Med Biol; 2008 Jan; 34(1):22-30. PubMed ID: 17854984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
    Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional myocardial blood flow and coronary vascular reserve in unanesthetized ponies during pacing-induced ventricular tachycardia.
    Parks C; Manohar M; Lundeen G
    J Surg Res; 1983 Aug; 35(2):119-31. PubMed ID: 6887834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography.
    Sambuceti G; Parodi O; Marcassa C; Neglia D; Salvadori P; Giorgetti A; Bellina RC; Di Sacco S; Nista N; Marzullo P
    Am J Cardiol; 1993 Sep; 72(7):538-43. PubMed ID: 8362767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.